Vilin Bio Med Ltd

NSE: VILINBIO · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹51.25
Market cap: ₹78.16 Cr
Revenue (annual): ₹42.26 Cr
Net profit (annual): ₹1.93 Cr
P/E (TTM): 40.5×Sector 47.3×
Promoter holding: 56.65%-2.92% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Merger & Restructuring 3 Management Change 3 Financial Results 2 Board Meeting Date 2 Annual General Meeting 2 Promoter Reclassification 1 Capital Structure Change 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 May 2026 14:17 IST NSE

Financial Results

Vilin Bio Med H2 FY26 Results: Net Profit ₹1.8 Cr, Up 1700.0% YoY

Vilin Bio Med Ltd reported revenue from operations of ₹32.6 Cr (+216.5% YoY) and net profit of ₹1.8 Cr (+1700.0% YoY) for H2 FY26.

Key figure: Net profit ₹1.8 Cr · +1700.0% YoY

Open full results → Read the filing ↗

30 May 2026 14:16 IST NSE

Financial Results

Vilin Bio Med Financial Results

Vilin Bio Med reported its FY2026 audited financial results following board approval. The company maintained steady operations with no reported deviations in fund utilization.

Read the filing ↗